Tag: GlaxoSmithKline
-
Zofran MDL For Lawsuits Filed In Federal Court Has Been Requested By Defendant Drug Company GlaxoSmithKline
And It Is Possible That Generic Zofran / Ondansetron – Birth Defects Cases Might Be Filed In California And Some Other State Courts (Posted by Tom Lamb at DrugInjuryWatch.com) On July 6,…
-
With Zofran – Birth Defects Lawsuits Filed, How Will GlaxoSmithKline Update Its Drug Label To Comply With New FDA Rule Effective June 2015
New FDA Rule Requires Drug Company To Replace Current Simple Pregnancy Category Designation With A Summary Of The Risks Of Using Zofran During Pregnancy (Posted by Tom Lamb at DrugInjuryWatch.com) ____________________________ UPDATE: …
-
Actos And Avandia Use Associated With Diabetic Macular Edema, Which Can Lead To Blindness
New UK Study Found Three To Six Times Increased Risk Of Developing This Retinal Eye Disease Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Avandia, Actos May Raise Risk of Macular Edema…
-
Avandia Recall Decision In Europe To Be Announced On Or About September 23, 2010
Will This September 2010 EMA Committee Meeting Result In A Consensus, Unlike July 2010 FDA Avandia Panel Voting (Posted by Tom Lamb at DrugInjuryWatch.com) _______________________________________________________________________ UPDATE: FDA Keeps Diabetes Pill on Market; Europe Suspends Sales …
-
Popular Seizure And Bipolar Disorder Medication Lamictal Associated With Aseptic Meningitis In August 2010
FDA Working With GlaxoSmithKline To Update Label, Or Package Insert, And Patient Medication Guide To Warn About This Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com)On August 12, 2010 the FDA announced that Lamictal…
-
10,000 Avandia Lawsuits Settled For $460 Million While FDA Considers Possible Avandia Recall
During July 13-14, 2010 FDA Advisory Committee Meeting, Glaxo Settles Most Of The 13,000 Avandia Court Cases (Posted by Tom Lamb at DrugInjuryWatch.com) Bloomberg reporters Jef Feeley and Trista Kelley broke the news of…
-
Serevent, Advair, and Foradil: Despite The Increased Risk of Severe Asthma Episodes and Death, Monotherapy Use Continues
Numerous Safety Warnings From FDA About These LABA Asthma Drugs Have Seemingly Been Ignored By Patients, According To New Medco Study (Posted by Tom Lamb at DrugInjuryWatch.com) As some of you may recall, back…
-
Study About Using Glaxo’s Avodart To Prevent Prostate Cancer Finds Possible Heart Risk
Higher Rate Of Cardiac Failure In Men Taking Avodart (Dutasteride) – 0.7 Percent vs. 0.4 Percent For Those Taking The Placebo (Posted by Tom Lamb at DrugInjuryWatch.com) In the April 1, 2010 edition of…